Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBT Margin: 2010-2016

Historic EBT Margin for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to -2,801,840.35%.

  • Tenax Therapeutics' EBT Margin was N/A to -2,801,840.35% in Q4 2016 from the same period last year, while for Dec 2016 it was -3,418.46%, marking a year-over-year change of. This contributed to the annual value of 76,534.78% for FY2024, which is 4414312.00% up from last year.
  • Tenax Therapeutics' EBT Margin amounted to -2,801,840.35% in Q4 2016, which was down 39,455.64% from -7,083.29% recorded in Q2 2013.
  • Tenax Therapeutics' 5-year EBT Margin high stood at -301.12% for Q4 2012, and its period low was -2,801,840.35% during Q4 2016.
  • Over the past 1 years, Tenax Therapeutics' median EBT Margin value was -2,801,840.35% (recorded in 2016), while the average stood at -2,801,840.35%.
  • The largest annual percentage gain for Tenax Therapeutics' EBT Margin in the last 5 years was 1,019,043bps (2012), contrasted with its biggest fall of 1,538,948bps (2012).
  • Over the past 3 years, Tenax Therapeutics' EBT Margin (Quarterly) stood at -301.12% in 2012, then slumped by 433,253bps to -7,083.29% in 2013, then reached -2,801,840.35% in 2016.
  • Its EBT Margin stands at -2,801,840.35% for Q4 2016, versus -7,083.29% for Q2 2013 and -1,085.17% for Q1 2013.